rxstat › Shortages › Basiliximab

Basiliximab (Simulect) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Basiliximab products are in shortage in Canada (1 of 1 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

An immunosuppressant used to help prevent rejection after organ transplant.

Products affected
1 / 1
In shortage since
May 22, 2026
Reports on file
2
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Reports by product

The DIN is printed on your prescription label.

Active shortage
SIMULECT
20MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02242815 · since May 22, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
SIMULECT
20MG · POWDER FOR SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02242815 · ended Sep 9, 2024 · Disruption of the manufacture of the drug.

What's happening

Basiliximab is currently affected by an active shortage report filed with Health Canada by NOVARTIS PHARMACEUTICALS CANADA INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Basiliximab is classified under “IMMUNOSUPPRESSANTS” (ATC L04AC).

Recent changes

Common questions

What is Basiliximab used for?

An immunosuppressant used to help prevent rejection after organ transplant.

When will Basiliximab be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Basiliximab in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (immunosuppressants)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Abatacept (Orencia) No current shortage Azathioprine (Imuran) No current shortage Belimumab (Benlysta) No current shortage Etanercept (Rymti) No current shortage Ixekizumab (Taltz) No current shortage Mycophenolic Acid No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.